Evidence map›Paper›PMID 24831876›Full record

ArticlePrion2014

Prion diseases and adult neurogenesis: how do prions counteract the brain's endogenous repair machinery?

Aroa Relaño-Ginés, Sylvain Lehmann, Carole Crozet

Open access · bronzeAbstract read
In one paragraph

Article in Prion, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. PrP(C) from stem cells to cancer.Frontiers in cell and developmental biology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Aroa Relaño-GinésInstitut de Génétique Humaine; CNRS-UPR 1142; Montpellier, France.
Sylvain LehmannInstitut de Génétique Humaine; CNRS-UPR 1142; Montpellier, France; IRMB; INSERM-UM1 U1040; Pathophysiology, Diagnosis and Cell Therapy of Neurodegenerative Disorders; CHU de Montpellier; Montpellier, France.
Carole CrozetInstitut de Génétique Humaine; CNRS-UPR 1142; Montpellier, France; IRMB; INSERM-UM1 U1040; Pathophysiology, Diagnosis and Cell Therapy of Neurodegenerative Disorders; CHU de Montpellier; Montpellier, France.
Centre Hospitalier Universitaire de Montpellier · FRInserm · FRInstitut de Génétique Humaine · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scientific advances in stem cell biology and adult neurogenesis have raised the hope that neurodegenerative disorders could benefit from stem cell-based therapy. Adult neurogenesis might be part of the physiological regenerative process, however it might become impaired by the disease's mechanism and therefore contribute to neurodegeneration. In prion disorders this endogenous repair system has rarely been studied. Whether adult neurogenesis plays a role or not in brain repair or in the propagation of prion pathology remains unclear. We have recently investigated the status of adult neural stem cells isolated from prion-infected mice. We were able to show that neural stem cells accumulate and replicate prions thus resulting in an alteration of their neuronal destiny. We also reproduced these results in adult neural stem cells, which were infected in vitro. The fact that endogenous adult neurogenesis could be altered by the accumulation of misfolded prion protein represents another great challenge. Inhibiting prion propagation in these cells would thus help the endogenous neurogenesis to compensate for the injured neuronal system. Moreover, understanding the endogenous modulation of the neurogenesis system would help develop effective neural stem cell-based therapies.

Indexed as

AnimalsBrainCell Growth ProcessesCell LineMiceNeurogenesisPrion DiseasesPrionsStem CellsPrionscell therapyneurodegenerative diseasesneurogenesisprionstem cell

Identifiers

PMID24831876
PMCPMC4601379
OpenAlexW2012633971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.